American Society of Echocardiography recommendations for use of echocardiography in clinical trials: A report from the american society of echocardiography's guidelines and standards committee and the task force on echocardiography in clinical trials

Journal of the American Society of Echocardiography

Volumn 17, Issue 10, 2004, Pages 1086-1119

  Gottdiener, John S ^a,m   Bednarz, James ^b   Devereux, Richard ^c   Gardin, Julius ^d   Klein, Allan ^e   Manning, Warren J ^f   Morehead, Annitta ^e   Kitzman, Dalane ^g   Oh, Jae ^h   Quinones, Miguel ⁱ   Schiller, Nelson B ^j   Stein, James H ^k   Weissman, Neil J ^l  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c Division of Reproductive Endocrinology   (United States)

^d ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^h MAYO CLINIC   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^l WASHINGTON HOSPITAL CENTER   (United States)

^m AMERICAN SOCIETY OF ECHOCARDIOGRAPHY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; AMILORIDE; AMLODIPINE; ATENOLOL; ATORVASTATIN; BISOPROLOL; CAPTOPRIL; CARVEDILOL; CHLORTALIDONE; COLESTIPOL; DIURETIC AGENT; ENALAPRIL; FELODIPINE; FLUINDOSTATIN; HYDROCHLOROTHIAZIDE; IBOPAMINE; IRBESARTAN; ISRADIPINE; LACIDIPINE; LOSARTAN; METOPROLOL; MEVINOLIN; NICOTINIC ACID; NIFEDIPINE; PRAVASTATIN; PROBUCOL; RAMIPRIL; UNINDEXED DRUG; VERAPAMIL;

AORTA VALVE PROSTHESIS; ARTERY DILATATION; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CAROTID ARTERY; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE VOLUME; HEART LEFT VENTRICLE WALL; HEART SIZE; HEART VALVE PROSTHESIS; HUMAN; HYPERTENSION; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; M MODE ECHOCARDIOGRAPHY; MEDICAL EDUCATION; MITRAL VALVE; MITRAL VALVE PROSTHESIS; PRACTICE GUIDELINE; PULMONARY VALVE; QUALITY CONTROL; REPRODUCIBILITY; REVIEW; STRESS ECHOCARDIOGRAPHY; STROKE; SYSTOLE; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRICUSPID VALVE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 4644335341     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2004.07.013     Document Type: Article

References (255)

1. M.A. Quinones, P.S. Douglas, E. Foster ACC/AHA clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on clinical competence J Am Soc Echocardiogr 16 2003 379 402
2. M.K. Cahalan, W. Stewart, A. Pearlman American Society of Echocardiography and Society of Cardiovascular Anesthesiologists task force guidelines for training in perioperative echocardiography J Am Soc Echocardiogr 15 2002 647 652
3. J.M. Gardin, D.B. Adams, P.S. Douglas Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report J Am Soc Echocardiogr 15 2002 275 290
4. M.A. Quinones, C.M. Otto, M. Stoddard, A. Waggoner, W.A. Zoghbi Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography J Am Soc Echocardiogr 15 2002 167 184
5. D. Ehler, D.K. Carney, A.L. Dempsey Guidelines for cardiac sonographer education: recommendations of the American Society of Echocardiography Sonographer Training and Education Committee J Am Soc Echocardiogr 14 2001 77 84
6. J.S. Shanewise, A.T. Cheung, S. Aronson ASE/SCA guidelines for performing a comprehensive intraoperative multiplane transesophageal echocardiography examination: recommendations of the American Society of Echocardiography Council for Intraoperative Echocardiography and the Society of Cardiovascular Anesthesiologists Task Force for Certification in Perioperative Transesophageal Echocardiography J Am Soc Echocardiogr 12 1999 884 900
7. W.F. Armstrong, P.A. Pellikka, T. Ryan, L. Crouse, W.A. Zoghbi Stress echocardiography: recommendations for performance and interpretation of stress echocardiography: Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography J Am Soc Echocardiogr 11 1998 97 9104
8. M.D. Cheitlin, J.S. Alpert, W.F. Armstrong ACC/AHA guidelines for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography): developed in collaboration with the American Society of Echocardiography Circulation 95 1997 1686 1744
9. American Society of Echocardiography Recommendations for continuous quality improvement in echocardiography J Am Soc Echocardiogr 8 1995 S1 28
10. A.S. Pearlman, J.M. Gardin, R.P. Martin Guidelines for physician training in transesophageal echocardiography: recommendations of the American Society of Echocardiography Committee for Physician Training in Echocardiography J Am Soc Echocardiogr 5 1992 187 194
11. T. Edvardsen, B.L. Gerber, J. Garot, D.A. Bluemke, J.A. Lima, O.A. Smiseth Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans: validation against three-dimensional tagged magnetic resonance imaging Circulation 106 2002 50 56
12. R. Hoffmann, E. Altiok, B. Nowak Strain rate measurement by Doppler echocardiography allows improved assessment of myocardial viability in patients with depressed left ventricular function J Am Coll Cardiol 39 2002 443 449
13. M. Belohlavek, V.B. Bartleson, M.E. Zobitz Real-time strain rate imaging: validation of peak compression and expansion rates by a tissue-mimicking phantom Echocardiography 18 2001 565 571
14. T.P. Abraham, R.A. Nishimura, D.R. Holmes, M. Belohlavek, J.B. Seward Strain rate imaging for assessment of regional myocardial function: results from a clinical model of septal ablation Circulation 105 2002 1403 1406
15. J.U. Voight, B. Exner, K. Schmiedehausen, C. Huchzermeyer, U. Reulbach, U. Nixdorff Strain-rate imaging during dobutamine stress echocardiography provides objective evidence of inducible ischemia Circulation 107 2003 2120 2126
16. J.S. Gottdiener Overview of stress echocardiography: uses, advantages, and limitations Prog Cardiovasc Dis 43 2001 315 334
17. J. Krivokapich, J.S. Child, D.O. Walter, A. Garfinkel Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease J Am Coll Cardiol 33 1999 708 716
18. D. Joyce, M. Loebe, G.P. Noon Revascularization and ventricular restoration in patients with ischemic heart failure: the STICH trial Curr Opin Cardiol 18 2003 454 457
19. O. Rodevand, R. Bjornerheim, S. Aakhus, J. Kjekshus Left ventricular volumes assessed by different new three-dimensional echocardiographic methods and ordinary biplane technique Int J Card Imaging 14 1998 55 63
20. S.L. Mulvagh, A.N. De Maria, S.B. Feinstein Contrast echocardiography: current and future applications J Am Soc Echocardiogr 13 2000 331 342
21. H. Feigenbaum, R.L. Popp, S.B. Wolfe Ultrasound measurements of the left ventricle: a correlative study with angiocardiography Arch Intern Med 129 1972 461 467
22. E.D. Folland, A.F. Parisi, P.F. Moynihan, D.R. Jones, C.L. Feldman, D.E. Tow Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography: a comparison of cineangiographic and radionuclide techniques Circulation 60 1979 760 766
23. R. Erbel, W. Krebs, G. Henn Comparison of single-plane and biplane volume determination by two-dimensional echocardiography, 1: asymmetric model hearts Eur Heart J 3 1982 469 480
24. M.A. Quinones, A.D. Waggoner, L.A. Reduto A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography Circulation 64 1981 744 753
25. F.A. Tortoledo, M.A. Quinones, G.C. Fernandez, A.D. Waggoner, W.L. Winters Quantification of left ventricular volumes by two-dimensional echocardiography: a simplified and accurate approach Circulation 67 1983 579 584
26. B. Greenberg, M.A. Quinones, C. Koilpillai Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction: results of the SOLVD echocardiography substudy Circulation 91 1995 2573 2581
27. R.B. Devereux, T.G. Pickering, G.A. Harshfield Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress Circulation 68 1983 470 476
28. B.F. Byrd, D. Wahr, Y.S. Wang, A. Bouchard, N.B. Schiller Left ventricular mass and volume/mass ratio determined by two-dimensional echocardiography in normal adults J Am Coll Cardiol 6 1985 1021 1025
29. P.R. Liebson, R.B. Devereux, M.J. Horan Hypertension research: echocardiography in the measurement of left ventricular wall mass Hypertension 9 part 2 1987 II-2 5
30. J.M. Gardin, D.D. Savage, J.H. Ware, W.L. Henry Effect of age, sex and body surface area on echocardiographic left ventricular wall mass in normal subjects Hypertension 9 1987 II-36 9
31. N.B. Schiller Considerations in the standardization of measurement of left ventricular myocardial mass by two-dimensional echocardiography Hypertension 9 suppl II 1987 II-33 5
32. D.D. Savage, D. Levy, A.L. Dannenberg, R.J. Garrison, W.P. Castelli Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (the Framingham Study) Am J Cardiol 65 1990 371 376
33. P. Liebson Echocardiographic assessment of the left ventricle in hypertension: perspectives on epidemiologic studies and clinical trials J Vasc Biol Med 4 1993 285 310
34. Gottdiener, JG, Diamond, JA, Phillips RA. Hypertension: Impact of echocardiographic data on the mechanism of hypertension treatment options, prognosis, and assessment of therapy. In Otto, CM edit. The Practice of Clinical Echo Cardiography, Special Edition. Phildadelphia: WB Saunders; 2002. p 705-38.
35. D.D. Savage, R.J. Garrison, W.B. Kannel, D. Levy, K.M. Anderson, J. Stokes III, M. Feinleib, W.P. Castelli The spectrum of left ventricular hypertrophy in a general population: The Framingham Study Circulation 75 1987 126 133
36. J.M. Gardin, A. Arnold, J.S. Gottdiener Left ventricular mass in the elderly: the Cardiovascular Health Study Hypertension 29 1997 1095 1103
37. R.B. Devereux, D.R. Alonso, E.M. Lutas Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 57 1986 450 458
38. V. Palmieri, B. Dahlof, V. DeQuattro Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study: Prospective Randomized Study Evaluating Regression of Ventricular Enlargement J Am Coll Cardiol 34 1999 1625 1632
39. R.B. Devereux, M.J. Roman, M. Paranicas Impact of diabetes on cardiac structure and function: the Strong Heart Study Circulation 101 2000 2271 2276
40. N.B. Schiller, P.M. Shah, M. Crawford Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 1989 358 367
41. S.H. Park, C. Shub, T.P. Nobrega, K.R. Bailey, J.B. Seward Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: correlation with autopsy and M-mode echocardiography J Am Soc Echocardiogr 9 1996 119 128
42. D.L. King, A.S. Gopal, A.M. Keller, P.M. Sapin, K.M. Schroder Three-dimensional echocardiography: advances for measurement of ventricular volume and mass Hypertension 23 1994 I-172 9
43. S. Geil, L. Rao, T. Menzel Determination of left ventricular mass by transthoracic three-dimensional echocardiography in patients with dilated cardiomyopathy[in German] Z Kardiol 88 1999 922 931
44. H.P. Kuhl, A. Bucker, A. Franke Transesophageal 3-dimensional echocardiography: in vivo determination of left ventricular mass in comparison with magnetic resonance imaging J Am Soc Echocardiogr 13 2000 205 215
45. A.S. Gopal, A.M. Keller, Z. Shen Three-dimensional echocardiography: in vitro and in vivo validation of left ventricular mass and comparison with conventional echocardiographic methods J Am Coll Cardiol 24 1994 504 513
46. A.S. Gopal, M.D. Schnellbaecher, Z. Shen Clinical use of 3D echocardiography for serial assessment of left ventricular mass regression in hypertensive patients[abstract] J Am Soc Echocardiogr 8 1995 387
47. R.B. Himelman, M.M. Cassidy, J.S. Landzberg, N.B. Schiller Reproducibility of quantitative two-dimensional echocardiography Am Heart J 115 1988 425 431
48. G.A. Grandits, P.R. Liebson, S. Dianzumba, R.J. Prineas Echocardiography in multicenter clinical trials: experience from the Treatment of Mild Hypertension Study Control Clin Trials 15 1994 395 410
49. V. Palmieri, B. Dahlof, V. DeQuattro Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study: Prospective Randomized Study Evaluating Regression of Ventricular Enlargement J Am Coll Cardiol 34 1999 1625 1632
50. R.B. Himelman, M.M. Cassidy, J.S. Landzberg, N.B. Schiller Reproducibility of quantitative two-dimensional echocardiography Am Heart J 115 1988 425 431
51. J.S. Gottdiener, S.V. Livengood, P.S. Meyer, G.A. Chase Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function J Am Coll Cardiol 25 1995 424 430
52. J.A. Mondelli, S. Di Luzio, A. Nagaraj The validation of volumetric real-time 3-dimensional echocardiography for the determination of left ventricular function J Am Soc Echocardiogr 14 2001 994 991000
53. M. Belohlavek, C. Pislaru, R.Y. Bae, J.F. Greenleaf, J.B. Seward Real-time strain rate echocardiographic imaging: temporal and spatial analysis of postsystolic compression in acutely ischemic myocardium J Am Soc Echocardiogr 14 2001 360 369
54. M.A. Quinones, C.M. Otto, M. Stoddard, A. Waggoner, W.A. Zoghbi Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography J Am Soc Echocardiogr 15 2002 167 184
55. C. Bruch, A. Schmermund, T. Bartel, J. Schaar, R. Erbel Tissue Doppler imaging: a new technique for assessment of pseudonormalization of the mitral inflow pattern Echocardiography 17 2000 539 546
56. S.F. Nagueh, K.J. Middleton, H.A. Kopelen, W.A. Zoghbi, M.A. Quinones Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures J Am Coll Cardiol 30 1997 1527 1533
57. G. Shimizu, M.R. Zile, A.S. Blaustein, W.H. Gaasch Left ventricular chamber filling and midwall fiber lengthening in patients with left ventricular hypertrophy: overestimation of fiber velocities by conventional midwall measurements Circulation 71 1985 266 272
58. G. De Simone, R.B. Devereux, M.J. Roman Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension[published erratum appears in J Am Coll Cardiol 1994;24:844] J Am Coll Cardiol 23 1994 1444 1451
59. G.P. Aurigemma, J.S. Gottdiener, L. Shemanski, J.M. Gardin, D. Kitzman Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the Cardiovascular Health Study J Am Coll Cardiol 37 2001 1042 1048
60. R.E. Schmieder Salt intake is related to the process of myocardial hypertrophy in essential hypertension JAMA 262 1989 1187 1188
61. H.L. Thomson, A.J. Basmadjian, A.J. Rainbird Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study J Am Coll Cardiol 38 2001 867 875
62. M.L. Chuang, M.G. Hibberd, C.J. Salton Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: assessment by two- and three-dimensional echocardiography and magnetic resonance imaging J Am Coll Cardiol 35 2000 477 484
63. W.G. Hundley, A.M. Kizilbash, I. Afridi, F. Franco, R.M. Peshock, P.A. Grayburn Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging J Am Coll Cardiol 32 1998 1426 1432
64. F. Grothues, G.C. Smith, J.C. Moon Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy Am J Cardiol 90 2002 29 34
65. E. Foster, M.K. Cahalan The search for intelligent quantitation in echocardiography: eyeball, trackball and beyond J Am Coll Cardiol 22 1993 848 850
66. M.D. Cerqueira, N.J. Weissman, V. Dilsizian Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 2002 539 542
67. N.B. Schiller, P.M. Shah, M. Crawford Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 1989 358 367
68. G.S. Hillis, J.E. Moller, P.A. Pellikka Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarction J Am Coll Cardiol 43 2004 360 367
69. T.S. Tsang, M.E. Barnes, B.J. Gersh, K.R. Bailey, J.B. Seward Risks for atrial fibrillation and congestive heart failure in patients 65 years of age with abnormal left ventricular diastolic relaxation Am J Cardiol 93 2004 54 58
70. J.E. Moller, S.H. Poulsen, E. Sondergaard, J.B. Seward, C.P. Appleton, K. Egstrup Impact of early changes in left ventricular filling pattern on long-term outcome after acute myocardial infarction Int J Cardiol 89 2003 207 215
71. M. Wang, G.W. Yip, A.Y. Wang Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value J Am Coll Cardiol 41 2003 820 826
72. J.E. Moller, K. Egstrup, L. Kober, S.H. Poulsen, O. Nyvad, C. Torp-Pedersen Prognostic importance of systolic and diastolic function after acute myocardial infarction Am Heart J 145 2003 147 153
73. T.S. Tsang, B.J. Gersh, C.P. Appleton Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women J Am Coll Cardiol 40 2002 1636 1644
74. G.A. Whalley, R.N. Doughty, G.D. Gamble Pseudonormal mitral filling pattern predicts hospital re-admission in patients with congestive heart failure J Am Coll Cardiol 39 2002 1787 1795
75. J.N. Bella, V. Palmieri, M.J. Roman Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study Circulation 105 2002 1928 1933
76. C.M. Schannwell, F.C. Schoebel, R. Marx, G. Plehn, M. Leschke, B.E. Strauer Prognostic relevance of left ventricular diastolic function parameters in dilated cardiomyopathy[in German] Z Kardiol 90 2001 269 279
77. P.L. Temporelli, U. Corra, A. Imparato, E. Bosimini, F. Scapellato, P. Giannuzzi Reversible restrictive left ventricular diastolic filling with optimized oral therapy predicts a more favorable prognosis in patients with chronic heart failure J Am Coll Cardiol 31 1998 1591 1597
78. G.I. Cohen, J.F. Pietrolungo, J.D. Thomas, A.L. Klein A practical guide to assessment of ventricular diastolic function using Doppler echocardiography J Am Coll Cardiol 27 1996 1753 1760
79. M.J. Garcia, J.D. Thomas, A.L. Klein New Doppler echocardiographic applications for the study of diastolic function J Am Coll Cardiol 32 1998 865 875
80. R.A. Nishimura, A.J. Tajik Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone J Am Coll Cardiol 30 1997 8 18
81. W.L. Border, E.C. Michelfelder, B.J. Glascock Color M-mode and Doppler tissue evaluation of diastolic function in children: simultaneous correlation with invasive indices J Am Soc Echocardiogr 16 2003 988 994
82. J.E. Moller, S.H. Poulsen, E. Sondergaard, K. Egstrup Preload dependence of color M-mode Doppler flow propagation velocity in controls and in patients with left ventricular dysfunction J Am Soc Echocardiogr 13 2000 902 909
83. M.J. Garcia, N.G. Smedira, N.L. Greenberg Color M-mode Doppler flow propagation velocity is a preload insensitive index of left ventricular relaxation: animal and human validation J Am Coll Cardiol 35 2000 201 208
84. M. Galderisi, E.J. Benjamin, J.C. Evans Intra- and interobserver reproducibility of Doppler-assessed indexes of left ventricular diastolic function in a population-based study (the Framingham Heart Study) Am J Cardiol 70 1992 1341 1346
85. C.P. Appleton, J.M. Galloway, M.S. Gonzalez, M. Gaballa, M.A. Basnight Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease: additional value of analyzing left atrial size, left atrial ejection fraction and the difference in duration of pulmonary venous and mitral flow velocity at atrial contraction J Am Coll Cardiol 22 1993 1972 1982
86. T. Maeda, M. Matsuzaki, Y. Anno Two-dimensional echocardiographic evaluation of left atrial shape and size[in Japanese] J Cardiogr 14 1984 311 321
87. S.J. Lester, E.W. Ryan, N.B. Schiller, E. Foster Best method in clinical practice and in research studies to determine left atrial size Am J Cardiol 84 1999 829 832
88. B. Kircher, J.A. Abbott, S. Pau Left atrial volume determination by biplane two-dimensional echocardiography: validation by cine computed tomography Am Heart J 121 1991 864 871
89. A.M. Pritchett, S.J. Jacobsen, D.W. Mahoney, R.J. Rodeheffer, K.R. Bailey, M.M. Redfield Left atrial volume as an index of left atrial size: a population-based study J Am Coll Cardiol 41 2003 1036 1043
90. T.A. Manolio, J.S. Gottdiener, T.S. Tsang, J.M. Gardin Left atrial dimensions determined by M-mode echocardiography in black and white older(65 years) adults (the Cardiovascular Health Study) Am J Cardiol 90 2002 983 987
91. J.M. Gardin, R. McClelland, D. Kitzman M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study) Am J Cardiol 87 2001 1051 1057
92. A. Rossi, M. Tomaino, G. Golia Usefulness of left atrial size in predicting postoperative symptomatic improvement in patients with aortic stenosis Am J Cardiol 86 2000 567 570
93. E.J. Benjamin, R.B. D'Agostino, A.J. Belanger, P.A. Wolf, D. Levy Left atrial size and the risk of stroke and death: the Framingham Heart Study Circulation 92 1995 835 841
94. J.S. Gottdiener, D.J. Reda, D.W. Williams, B.J. Materson, W. Cushman, R.J. Anderson Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: comparison of six antihypertensive agents: the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents Circulation 95 1998 2007 2014
95. F. Triposkiadis, K. Tentolouris, A. Androulakis Left atrial mechanical function in the healthy elderly: new insights from a combined assessment of changes in atrial volume and transmitral flow velocity J Am Soc Echocardiogr 8 1995 801 809
96. J.D. Pearlman, M.O. Triulzi, M.E. King, V.M. Abascal, J. Newell, A.E. Weyman Left atrial dimensions in growth and development: normal limits for two-dimensional echocardiography J Am Coll Cardiol 16 1990 1168 1174
97. N.B. Schiller, E. Foster, R.F. Redberg Transesophageal echocardiography in the evaluation of mitral regurgitation: the twenty-four signs of severe mitral regurgitation Cardiol Clin 11 1993 399 408
98. M.D. Cheitlin, W.F. Armstrong, G.P. Aurigemma ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 108 2003 1 17
99. A.E. Weyman Principles and practice of echocardiography 2nd ed 1994 Lea Febiger Philadelphia
100. Otto Catherine. Textbook of clinical echocardiography. 2nd ed. Philadelphia: WB Saunders; 2000. p. 521-46.
101. H. Feigenbaum Echocardiography 5th ed 1994 Lea Febiger Philadelphia
102. F. Recusani, G.S. Bargiggia, A.P. Yoganathan A new method for quantification of regurgitant flow rate using color Doppler flow imaging of the flow convergence region proximal to a discrete orifice: an in vitro study Circulation 83 1991 594 604
103. J.M. Rivera, P.M. Vandervoort, D.H. Thoreau, R.A. Levine, A.E. Weyman, J.D. Thomas Quantification of mitral regurgitation with the proximal flow convergence method: a clinical study Am Heart J 124 1992 1289 1296
104. M. Enriquez-Sarano, A.J. Tajik, K.R. Bailey, J.B. Seward Color flow imaging compared with quantitative Doppler assessment of severity of mitral regurgitation: influence of eccentricity of jet and mechanism of regurgitation J Am Coll Cardiol 21 1993 1211 1219
105. G.Y. Xie, M.R. Berk, C.S. Hixson, A.C. Smith, A.N. De Maria, M.D. Smith Quantification of mitral regurgitant volume by the color Doppler proximal isovelocity surface area method: a clinical study J Am Soc Echocardiogr 8 1995 48 54
106. G. Grossmann, A. Hoffmeister, A. Imhof, M. Giesler, V. Hombach, J. Spiess Reproducibility of the proximal flow convergence method in mitral and tricuspid regurgitation Am Heart J 147 2004 721 728
107. T. Hagenaars, E.J. Gussenhoven, J.A. van Essen, J. Seelen, J. Honkoop, L.A.Reproducibility of volumetric quantification in intravascular ultrasound images van der Ultrasound Med Biol 26 2000 367 374
108. G.S. Mintz, S.E. Nissen, W.D. Anderson Standards for the acquisition; measurement; and reporting of intravascular ultrasound studies: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents J Am Coll Cardiol 37 2001 1478 1492
109. J.A. Panza, A.A. Quyyumi, J.E. Brush, S.E. Epstein Abnormal endothelium-dependent relaxation in patients with essential hypertension N Engl J Med 323 1990 22 36
110. F. Perticone, R. Ceravalo, A. Pujia Prognostic significance of endothelial dysfunction in hypertensive patients Circulation 104 2001 191 196
111. T. Mano, T. Masuyama, K. Yamamoto Endothelial dysfunction in the early stage of atherosclerosis precedes appearance of intimal lesions assessable with intravascular ultrasound Am Heart J 131 1996 231 238
112. K.G. Reddy, R.N. Nair, H.M. Sheehan, J.M. Hodgson Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis J Am Coll Cardiol 23 1994 838 843
113. G.P. Nieuw Amerongen, M.A. Vermeer, P. Negre-Aminou, J. Lankelma, J.J. Emeis, V.W. van Hinsbergh Simvastatin improves disturbed endothelial barrier function Circulation 102 2000 2803 2809
114. W.F. Penny, O. Ben Yehuda, K. Kuroe Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein J Am Coll Cardiol 37 2001 766 774
115. T. Neunteufl, K. Kostner, R. Katzenschlager, M. Zehetgruber, G. Maurer, F. Weidinger Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men J Am Coll Cardiol 32 1998 711 716
116. M.C. Corretti, T.J. Anderson, E.J. Benjamin Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265
117. K.E. Sorensen, D.S. Celermajer, D.J. Spiegelhalter Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility Br Heart J 74 1995 247 253
118. J.T. Salonen, R. Salonen Ultrasound B-mode imaging in observational studies of atherosclerotic progression Circulation 87 1993 1156 1165
119. G. Burke, G. Evans, W. Riley Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study Stroke 26 1995 386 391
120. L.E. Chambless, G. Heiss, A.R. Folsom Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993 Am J Epidemiol 146 1997 483 494
121. D. O'Leary, J. Polak, R. Kronmal, T. Manolio, G. Burke, S. Wolfson Jr Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study N Engl J Med 340 1999 14 22
122. M.A. Espeland, T.E. Craven, W.A. Riley, J. Corson, A. Romont, C.D. Furberg Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thicknesses: Asymptomatic Carotid Artery Progression Study Research Group Stroke 27 1996 480 485
123. R. Tang, M. Hennig, B. Thomasson Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA) J Hypertens 18 2000 197 201
124. G. Howard, A. Sharret, G. Heiss, G.W. Evans, L.E. Chambless, W.A. Riley Carotid artery intimal-media thickness distribution in general populations as evaluated by B-mode ultrasound Stroke 24 1993 1297 1304
125. A. Zanchetti, M.G. Bond, M. Hennig Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial Circulation 106 2002 2422 2427
126. R.H. Selzer, H.N. Hodis, H. Kwong-Fu Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images Atherosclerosis 111 1994 1 11
127. W. Riley, R. Barnes, M. Bond High-resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities (ARIC) cohort J Neuroimaging 1 1991 168 172
128. I. Wendelhag, Q. Liang, T. Gustavsson, J. Wikstrand A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness Stroke 28 1997 2195 2200
129. G. Gerstenblith, J. Frederiksen, F.C. Yin, N. Fortuin, E. Lakatta, M.L. Weisfeldt Echocardiographic assessment of a normal adult aging population Circulation 56 1977 273 278
130. J.M. Gardin, W.L. Henry, D.D. Savage, J.H. Ware, C. Burn, J.S. Borer Echocardiographic measurements in normal subjects: evaluation of an adult population without clinically apparent heart disease J Clin Ultrasound 7 1979 439 447
131. W.L. Henry, J.M. Gardin, J.H. Ware Echocardiographic measurements in normal subjects from infancy to old age Circulation 62 2003 1054 1061
132. R. Valdez, J. Motta, E. London Evaluation of the echocardiogram as an epidemiologic tool in an asymptomatic population Circulation 60 1979 921 929
133. D.D. Savage, R.D. Abbott, S.J. Padgett, S.J. Anderson, R.J. Garrison Epidemiologic aspects of left ventricular hypertrophy in normotensive and hypertensive subjects H.E.D.J. ter Keurs Cardiac Left Ventricular Hypertrophy 1983 Martinus-Nijhoff The Hague 2 15
134. D.D. Savage, R.J. Garrison, W.B. Kannel, S.J. Anderson, M. Feinleib, W.P. Castelli Considerations in the use of echocardiography in epidemiology: the Framingham study Hypertension 9 Suppl II 1987 II-40 4
135. D.D. Savage, R.J. Garrison, W.B. Kannel The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study Circulation 75 1987 I-26 33
136. D. Levy, R.J. Garrison, D.D. Savage, W.B. Kannel, W.P. Castelli Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study Ann Intern Med 110 1989 101 107
137. D. Levy, R.J. Garrison, D.D. Savage, W.B. Kannel, W.P. Castelli Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 332 1990 1561 1566
138. P.R. Liebson Clinical studies of drug reversal of hypertensive left ventricular hypertrophy Am J Hypertens 3 1990 512 517
139. B. Trimarco, J. Wikstrand Regression of cardiovascular structural changes by antihypertensive treatment: functional consequences and time course of reversal as judged from clinical studies Hypertension 6 Suppl 3 1984 III-150
140. S.P. Schulman, J.L. Weiss, L.C. Becker The effects of antihypertensive therapy on left ventricular mass in elderly patients N Engl J Med 322 1990 1350 1356
141. S. Sen Regression of cardiac hypertrophy: experimental animal model Am J Med 75 Suppl 3A 1983 87
142. F. Fouad-Tarazi, P.R. Liebson Echocardiographic studies of regression of left ventricular hypertrophy in hypertension Hypertension 4 Suppl 2 1987 65 68
143. R.C. Tarazi, S. Sen, F.M. Fouad, P. Wicker Regression of myocardial hypertrophy: conditions and sequelae of reversal in hypertensive heart disease N.R. Alpert Perspectives in Cardiovascular Research, 7th ed 1983 Raven Press New York 637
144. J.S. Gottdiener, D.J. Reda, B.M. Massie, B.J. Materson, D.W. Williams, R.J. Anderson Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents: the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents Circulation 95 1997 2007 2014
145. V. Papademetriou, J.S. Gottdiener, P. Narayan Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial: the Isradipine Study Group J Am Coll Cardiol 30 1997 1802 1808
146. B. Dahlof, R. Devereux, U. de Faire The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods: the LIFE Study Group Am J Hypertens 10 1997 705 713
147. W. Mazur, S.F. Nagueh, N.M. Lakkis Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic
148. G. De Simone, L.A. Ferrara, L. Di Lorenzo, R. Lauria, M.L. Fasano Effects of slow-release nifedipine of left ventricular mass and systolic function in mild or moderate hypertension Curr Ther Res 36 1984 537 544
149. B. Trimarco, N. De Luca, B. Ricciardelli Cardiac function in systemic hypertension before and after reversal of left ventricular hypertrophy Am J Cardiol 62 1988 745 750
150. M. Shahi, S. Thom, N. Poulter, P.S. Sever, R.A. Foale Regression of hypertensive left ventricular hypertrophy and left ventricular diastolic function Lancet 336 1990 458 461
151. A.M. Grandi, A. Venco, A. Bertolini Left ventricular function after reversal of myocardial hypertrophy in systemic hypertension, and response to acute increase of afterload by cold pressor test Am J Cardiol 69 1992 1439 1441
152. Galderisi M, Celentano A, Garofalo M, T, et al. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril. Int J Clin Pharmacol Ther 1994;32:312-6.
153. Y. Lacourciere, L. Poirier, J. Cleroux Physical performance is preserved after regression of left ventricular hypertrophy J Cardiovasc Pharmacol 30 1997 383 391
154. R.B. Devereux, B. Dahlof, D. Levy, M.A. Pfeffer Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial) Am J Cardiol 78 1996 61 65
155. I.W. Franz, U. Tonnesmann, J.F. Muller Time course of complete normalization of left ventricular hypertrophy during long-term antihypertensive therapy with angiotensin converting enzyme inhibitors Am J Hypertens 11 1998 631 639
156. J.S. Gottdiener Clinical trials of single-drug therapy for the cardiac effects of hypertension Am J Hypertens 12 1999 12S 18
157. R.A. Phillips, M. Ardeljan, S. Shimabukuro Effects of nifedipine-GITS on left ventricular mass and left ventricular filling J Cardiovasc Pharmacol 19 Suppl 2 1992 S28 34
158. Aurigemma GP, Gottdiener JS, Gaasch WH, et al. Ventricular and myocardial function following regression of hypertensive left ventricular hypertrophy. J Am Coll Cardiol 1995;February (special issue):251A.
159. K. Wachtell, J.N. Bella, J. Rokkedal Change in diastolic left ventricular filling after one year of antihypertensive treatment: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study Circulation 105 2002 1071 1076
160. J.S. Gottdiener, J.A. Diamond, R.A. Phillips Hypertension: impact of echocardiographic data on the mechanism of hypertension, treatment options, prognosis and assessment of therapy C.M. Otto Clinical Echocardiography, 2nd ed 2000 WB Saunders Philadelphia
161. Heart Failure Society of America (HFSA) practice guidelines HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction: pharmacological approaches J Card Fail 5 1999 357 382
162. Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure) J Am Coll Cardiol 26 1995 1376 1398
163. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med. 325 1991 293 302
164. D.J. Pennell, S.G. Ray, G. Davies The Carvedilol Hibernation Reversible Ischaemia Trial, Marker of Success (CHRISTMAS) Study: methodology of a randomised; placebo controlled; multicentre study of carvedilol in hibernation and heart failure Int J Cardiol 72 2000 265 274
165. M. Wong, L. Staszewsky, A. Volpi, R. Latini, S. Barlera, C. Hoglund Quality assessment and quality control of echocardiographic performance in a large multicenter international study: Valsartan in Heart Failure Trial (Val-HeFT) J Am Soc Echocardiogr 15 2002 293 301
166. S. Sasayama Prognosis of heart failure and factors influencing mortality[in Japanese] Nippon Rinsho 51 2003 1379 1392
167. J.G. Cleland, M. Tendera, J. Adamus PEP Investigators Perindopril for elderly people with chronic heart failure: the PEP-CHF study Eur J Heart Fail 1 1999 211 217
168. M. Wong, T. Germanson, W.R. Taylor Felodipine improves left ventricular emptying in patients with chronic heart failure: V-HeFT III echocardiographic substudy of multicenter reproducibility and detecting functional change J Card Fail 6 2000 19 28
169. W.T. Abraham, W.G. Fisher, A.L. Smith Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
170. A. Capucci, S. Romano, A. Puglisi Dual chamber pacing with optimal AV delay in congestive heart failure: a randomized study Europace 1 1999 174 178
171. W.T. Abraham, W.G. Fisher, A.L. Smith Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
172. M.V. Pitzalis, M. Iacoviello, R. Romito Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony J Am Coll Cardiol 40 2002 1615 1622
173. P. Sogaard, H. Egeblad, W.Y. Kim Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy J Am Coll Cardiol 40 2002 723 730
174. N.G. Bellenger, M.I. Burgess, S.G. Ray Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance: are they interchangeable? Eur Heart J 21 2000 1387 1396
175. 1999 Heart and Stroke Statistical Update. Dallas Tex: American Heart Association, 1998.
176. R.G. Hart Cardiogenic embolism to the brain Lancet 339 1992 589 594
177. M.E. Goldman, L.B. Croft, M.E. Goldman, L.B. Croft Echocardiography in search of a cardioembolic source Curr Probl Cardiol 27 2002 342 348
178. A.L. Klein, R.A. Grimm, R.D. Murray Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation N Engl J Med 344 2001 1411 1420
179. M.R. Di Tullio, S. Homma Mechanisms of cardioembolic stroke Curr Cardiol Rep 4 2002 141 148
180. A.L. Klein Emerging role of echocardiography in the evaluation of patients with atrial fibrillation into the new millennium Echocardiography 17 2000 353 356
181. M. Thamilarasan, A.L. Klein Transesophageal echocardiography (TEE) in atrial fibrillation Cardiol Clin 18 2000 819 831
182. C. Rodriguez, S. Homma, M. Di Tullio Transesophageal echocardiography in stroke Cardiol Rev 8 2000 140 147
183. S. Homma, R.L. Sacco, M.R. Di Tullio, R.R. Sciacca, J.P. Mohr Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study Circulation 105 2002 2625 2631
184. A. Mugge, H. Kuhn, P. Nikutta, J. Grote, J.A. Lopez, W.G. Daniel Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk J Am Coll Cardiol 23 1994 599 607
185. M.E. Goldman, L.A. Pearce, R.G. Hart Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation, I: reduced flow velocity in the left atrial appendage (the Stroke Prevention in Atrial Fibrillation[SPAF- III] study) J Am Soc Echocardiogr 12 1999 1080 1087
186. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation Ann Intern Med 128 1998 639 647
187. M. Zabalgoitia, J.L. Halperin, L.A. Pearce, J.L. Blackshear, R.W. Asinger, R.G. Hart Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation: Stroke Prevention in Atrial Fibrillation III Investigators J Am Coll Cardiol 31 1998 1622 1626
188. J.P. Mohr, J.L. Thompson, R.M. Lazar A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke N Engl J Med 345 2001 1444 1451
189. D.Y. Leung, R.A. Grimm, A.L. Klein Transesophageal echocardiography- guided approach to cardioversion of atrial fibrillation Prog Cardiovasc Dis 39 1996 21 32
190. T. Nakai, M.D. Lesh, E.P. Gerstenfeld, R. Virmani, R. Jones, R.J. Lee Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine model Circulation 105 2002 2217 2222
191. J.M. Kalman, J.E. Olgin, M.R. Karch, M.D. Lesh Use of intracardiac echocardiography in interventional electrophysiology Pacing Clin Electrophysiol 20 1997 2248 2262
192. R.H. Sohn, N.B. Schiller Left upper pulmonary vein stenosis 2 months after radiofrequency catheter ablation of atrial fibrillation Circulation 101 2000 e154 5
193. A. Khositseth, A.K. Cabalka, J.P. Sweeney Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism Mayo Clin Proc 79 2004 35 41
194. M.G. Earing, A.K. Cabalka, J.B. Seward, C.J. Bruce, G.S. Reeder, D.J. Hagler Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale Mayo Clin Proc 79 2004 24 34
195. US Food and Drug Administration. Heart Valve Guidance, Version 4.1. 1994.
196. A.J. Labovitz Assessment of prosthetic heart valve function by Doppler echocardiography. a decade of experience Circulation 80 1989 707 709
197. M. Tsukamoto, S. Inoue, T. Ito, Y. Hachiro, S. Muraki, T. Abe Functional evaluation of the bileaflet mechanical valve in the aortic position using dobutamine-stress echocardiography: is a 23-mm prosthetic valve adequately large enough? Jpn Circ J 62 1998 817 823
198. S.A. Reisner, R.S. Meltzer Normal values of prosthetic valve Doppler echocardiographic parameters: a review J Am Soc Echocardiogr 1 1998 201 210
199. L. Olmos, G. Salazar, J. Barbetseas, M.A. Quiñones, W.A. Zoghbi Usefulness of transthoracic echocardiography in detecting significant prosthetic mitral valve regurgitation Am J Cardiol 83 1999 199 205
200. E.R. Chafizadeh, W.A. Zoghbi Doppler echocardiographic assessment of the St Jude Medical prosthetic valve in the aortic position using the continuity equation Circulation 83 2003 213 223
201. H. Baumgartner, H. Kratzer, G. Helmreich, P. Kuehn Determination of aortic valve area by Doppler echocardiography using the continuity equation: a critical evaluation Cardiology 77 1990 101 111
202. F.A. Flachskampf, J.P. O'Shea, B.P. Griffin, L. Guerrero, A.E. Weyman, J.D. Thomas Patterns of normal transvalvular regurgitation in mechanical valve prostheses J Am Coll Cardiol 18 1991 1493 1498
203. D.J. Burstow, R.A. Nishimura, K.R. Bailey Continuous wave Doppler echocardiographic measurement of prosthetic valve gradients: a simultaneous Doppler-catheter correlative study Circulation 80 1989 504 514
204. H. Baumgartner, S. Khan, M. DeRobertis, L. Czer, G. Maurer Discrepancies between Doppler and catheter gradients in aortic prosthetic valves in vitro: a manifestation of localized gradients and pressure recovery Circulation 82 1990 1467 1475
205. K.L.A.U. Yun, C.F. Sintek, A.D. Fletcher Aortic valve replacement with the freestyle stentless bioprosthesis: five-year experience Circulation 100 1999 17 23
206. H. Baumgartner, S. Khan, M. DeRobertis, L. Czer, G. Maurer Effect of prosthetic aortic valve design on the Doppler-catheter gradient correlation: an in vitro study of normal St Jude, Medtronic-Hall, Starr-Edwards and Hancock valves J Am Coll Cardiol 19 1992 324 332
207. S. Mohr-Kahaly, I. Kupferwasser, R. Erbel, H. Oelert, J. Meyer Regurgitant flow in apparently normal valve prostheses: improved detection and semiquantitative analysis by transesophageal two-dimensional color-coded Doppler echocardiography J Am Soc Echocardiogr 3 1990 187 195
208. J.G. Dumesnil, G.N. Honos, M. Lemieux, J. Beauchemin Validation and applications of mitral prosthetic valvular areas calculated by Doppler echocardiography Am J Cardiol 65 1990 1443 1448
209. J.N. Bitar, M.E. Lechin, G. Salazar, W.A. Zoghbi Doppler echocardiographic assessment with the continuity equation of St Jude Medical mechanical prostheses in the mitral valve position Am J Cardiol 76 2003 287 293
210. L.B. Daniel, L.E. Grigg, R.D. Weisel, H. Rakowski Comparison of transthoracic and transesophageal assessment of prosthetic valve dysfunction Echocardiography 7 1990 83 95
211. B.K. Khandheria, J.B. Seward, J.K. Oh Value and limitations of transesophageal echocardiography in assessment of mitral valve prostheses Circulation 83 1991 1956 1968
212. T. Hole, J.E. Otterstad, S.M. St John, G. Froland, I. Holme, T. Skjaerpe Differences between echocardiographic measurements of left ventricular dimensions and function by local investigators and a core laboratory in a 2-year follow-up study of patients with an acute myocardial infarction Eur J Echocardiogr 3 2002 263 270
213. J.K. Oh Is core laboratory essential for using echocardiography in clinical trials? Controlled vs random error Eur J Echocardiogr 3 2002 245 247
214. D. Ehler, D.K. Carney, A.L. Dempsey Guidelines for cardiac sonographer education: recommendations of the American Society of Echocardiography Sonographer Training and Education Committee J Am Soc Echocardiogr 14 2001 77 84
215. H. Hodis, W. Mack, L. LaBree The role of carotid arterial intima-medial thickness in predicting clinical coronary events Ann Intern Med 128 1998 262 269
216. A.J. Taylor, S.M. Kent, P.J. Flaherty, L.C. Coyle, T.T. Markwood, M.N. Vernalis ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness Circulation 106 2002 2055 2060
217. Y. Sawayama, C. Shimizu, N. Maeda Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia: Fukuoka Atherosclerosis Trial (FAST) J Am Coll Cardiol 39 2002 610 616
218. R.P. Byington, C.D. Furberg, J.R. Crouse III, M.A. Espeland, M.G. Bond Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II) Am J Cardiol 76 1995 54C 59C
219. T.J. Smilde, S. van Wissen, H. Wollersheim, M.D. Trip, J.J. Kastelein, A.F. Stalenhoef Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective; randomised; double-blind trial Lancet 357 2001 577 581
220. S. MacMahon, N. Sharpe, G. Gamble Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy: LIPID Trial Research Group Circulation 97 1998 1784 1790
221. B. Hedblad, J. Wikstrand, L. Janzon, H. Wedel, G. Berglund Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS) Circulation 103 2001 1721 1726
222. R. Salonen, K. Nyyssonen, E. Porkkala Kuopio Atherosclerosis Prevention Study (KAPS): a population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries Hypertension 92 2003 1758 1764
223. E. de Groot, J.W. Jukema, A.D. Montauban van Swijndregt B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS) J Am Coll Cardiol 31 1998 1561 1567
224. M. Mercuri, M.G. Bond, C.R. Sirtori Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study Am J Med 101 1996 627 634
225. H.N. Hodis, W.J. Mack, L. LaBree Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial Ann Intern Med 124 1996 548 556
226. B. Pitt, R.P. Byington, C.D. Furberg Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events: PREVENT Investigators Circulation 102 2000 1503 1510
227. N.O. Borhani, M. Mercuri, P.A. Borhani Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS): a randomized controlled trial JAMA 276 2003 785 791
228. A. Zanchetti, E.A. Rosei, C. Dal Palu, G. Leonetti, B. Magnani, A. Pessina The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness J Hypertens 16 1998 1667 1676
229. A. Simon, J. Gariepy, G. Chironi, J.L. Megnien, J. Levenson Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk J Hypertens 20 2002 159 169
230. E. Lonn, S. Yusuf, V. Dzavik Effects of ramipril and vitamin E on atherosclerosis: the Study to Evaluate Carotid Ultrasound Changes in Patients Treated With Ramipril and Vitamin E (SECURE) Circulation 103 2001 919 925
231. D.D. Savage, A.R. Garrison, W.B. Kannel The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study Circulation 75 1987 I26 33
232. I.W. Hammond, R.B. Devereux, M.A. Aldermann The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension J Am Coll Cardiol 7 1986 639 650
233. M. Senni, C.M. Tribouilloy, R.J. Rodeheffer Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991 Circulation 98 1998 2282 2289
234. J.M. Gardin, N.D. Wong, W. Bommer Echocardiographic design of a multi-center investigation of free-living elderly subjects: the Cardiovascular Health Study J Am Soc Echocardiogr 5 1992 63 72
235. J.M. Gardin, L.E. Wagenknecht, H. Anton-Culver Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women: the CARDIA study: Coronary Artery Risk Development in Young Adults Circulation 92 1995 380 387
236. M. Lindroos, M. Kupari, J. Heikkila, R. Tilvis Echocardiographic evidence of left ventricular hypertrophy in a general aged population Am J Cardiol 74 1994 385 390
237. A. Ilercil, M.J. O'Grady, M.J. Roman Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity: the Strong Heart Study J Am Soc Echocardiogr 14 2001 601 611
238. G. De Simone, V. Palmieri, J.N. Bella Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study J Hypertens 20 2002 323 331
239. R.B. Devereux, M.J. Roman, M. Paranicas A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study Am Heart J 141 2001 439 446
240. P.R. Liebson, G.A. Grandits, S. Dianzumba Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS) Circulation 91 1995 698 706
241. R.B. Devereux, V. Palmieri, J.E. Liu Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study J Hypertens 20 2002 1445 1450
242. R.B. Devereux, V. Palmieri, N. Sharpe Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PRESERVE) trial Circulation 104 2001 1248 1254
243. M. St. John Sutton, M.A. Pfeffer, T. Plappert Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction: the protective effects of captopril Circulation 89 1994 68 75
244. M. Wong, G. Johnson, R. Shabetai Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure: Veterans Affairs cooperative studies V-HeFT I and II: V-HeFT VA Cooperative Studies Group Circulation 87 1993 V165 70
245. CIBIS-II Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
246. S.A. Hall, C.G. Cigarroa, L. Marcoux, R.C. Risser, P.A. Grayburn, E.J. Eichhorn Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade J Am Coll Cardiol 25 1995 1154 1161
247. R.N. Doughty, G.A. Whalley, G. Gamble, S. MacMahon, N. Sharpe Australia-New Zealand Heart Failure Research Collaborative Group Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease J Am Coll Cardiol 29 1997 1060 1066
248. W.H.W. Tang, U.N. Khot, M.S. Larson Baseline clinical parameters do not predict left ventricular ejection improvement following carvedilol therapy in heart failure J Am Coll Cardiol 35 2000 207A
249. S.R. Arcensio, A.C. Barretto, F. Szambock Comparative study between ibopamine and captopril in mild and moderate heart failure: a double-blind study [in Portugese] Arq Bras Cardiol. 63 1994 409 413
250. M. Jette, R. Heller, F. Landry, G. Blumchen Randomized 4-week exercise program in patients with impaired left ventricular function Circulation 84 1991 1561 1567
251. C.T. Pu, M.T. Johnson, D.E. Forman Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure J Appl Physiol 90 2003 2341 2350
252. C.H. Cabell, E.J. Velazquez, J.G. Dumesnil Echocardiographic predictors of mortality in nonischemic cardiomyopathy: report from the PRAISE-2 Echocardiographic Substudy Am Coll Cardiol 37 2002 648A
253. K. Swedberg, M. Pfeffer, C. Granger Candesartan in Heart Failure - Assessment of Reduction in Mortality and Morbidity (CHARM): rationale and design: Charm-Programme Investigators J Card Fail 5 1999 276 282
254. R.D. Murray, A. Shah, S.E. Jasper Transesophageal echocardiography guided enoxaparin antithrombotic strategy for cardioversion of atrial fibrillation: the ACUTE II pilot study Am Heart J 139 2000 1 7
255. P.M. Pullicino, J.L. Halperin, J.L. Thompson Stroke in patients with heart failure and reduced left ventricular ejection fraction Neurology 54 2000 288 294